Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-24-000330
Filing Date
2024-08-07
Accepted
2024-08-07 09:39:54
Documents
4
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 04-30-2024 form_10-q.htm 10-Q 181677
2 SUBSIDIARIES OF THE REGISTRANT ex_21.htm EX-21 1761
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 6930
4 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3544
  Complete submission text file 0001161697-24-000330.txt   194986
Mailing Address 2500 CITYWEST BLVD. STE 150-161 HOUSTON TX 77042
Business Address 2500 CITYWEST BLVD. STE 150-161 HOUSTON TX 77042 (307) 228-1488
NEUTRA CORP. (Filer) CIK: 0001512886 (see all company filings)

EIN.: 274505461 | State of Incorp.: WY | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 000-55077 | Film No.: 241181981
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)